Literature DB >> 12064

Serum gamma-glutamyl transpeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills.

B Combes, G M Shore, F G Cunningham, F B Walker, J W Shorey, A Ware.   

Abstract

gamma-Glutamyl transpeptidase (GGT) activity in serum was increased in the majority of women with viral hepatitis occurring in the first half of pregnancy. By contrast, GGT activity was abnormal less frequently and the mean value was relatively depressed, even though hepatitis was as severe, in the second half of gestation. Mean GGT activity was also lower, and abnormal values were less frequent, in nonpregnant women with viral hepatitis who were taking birth control pills (BCP). Depressed GGT is not attributable to an inhibitor in serum in women in late pregnancy or taking BCP. The data suggest that estrogen and/or progestational compounds affect liver such that less GGT is released into blood with acute hepatocellular injury. In addition, hyperbilirubinemia was found to be associated with depressed serum GGT activity, and bilirubin added to serum in vitro interfered with measured activity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 12064

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Screening for alcohol abuse in pregnancy.

Authors:  I G Barrison; J T Wright; B Sampson; N F Morris; I M Murray-Lyon
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

Review 2.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

Review 3.  [Cholestasis and pregnancy: hepatopathies specific to pregnancy].

Authors:  G Dorta
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 4.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

5.  Clinical evaluation of liver structure and function in humans exposed to halogenated hydrocarbons.

Authors:  P S Guzelian
Journal:  Environ Health Perspect       Date:  1985-05       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.